References
- Fassas A, Passweg JR, Anagnostopoulos A, et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249: 1088–97
- Kozak T, Havrdova E, Pit'ha J, et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000; 25: 525–31
- Burt RK, Cohen BA, Russell E, et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis; failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003; 102: 2373–8
- Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003; 102: 2364–72
- Fassas A, Nash R. Multiple sclerosis. Best Prac Res Clin Hematol 2004; 17: 247–62
- Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938–52
- Muraro PA, McFarland HF, Martin R. Immunological aspects of multiple sclerosis with emphasis on the potential use of autologous hemopoietic stem cell transplantation. Stem Cell Therapy for Autoimmune Disease, RK Burt, AM Marmont. Landes Bioscience, Georgetown, TX 2004; 277–83
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis; an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–52
- Shevchenko Y, Novik A, Ionova T, et al. Clinical and quality of life outcomes in patients with multiple sclerosis after high-dose chemotherapy + autologous stem cell transplantation [abstract no. 1875]. Blood 2004; 104: 519a
- Shevchenko Y, Novik A, Ionova T, Kishtovich A. The method of integral profiles to study quality of life in rheumatoid arthritis patients. Bull Multinatl Cent Qual Life Res 2004; 3–4: 11–8
- McQuellon RP, Russell GB, Cella DF, et al. Quality of life measurement in bone marrow transplantation; development of the functional assessment of cancer therapy–bone marrow transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–68
- Burt RK, Padilla J, Begolka WS, et al. Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood 1998; 91: 2609–16